Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells.

Autor: Candas-Green D; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA., Xie B; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.; Center for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China., Huang J; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA., Fan M; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA., Wang A; Department of Surgery, School of Medicine, University of California Davis, Sacramento, CA, 95817, USA., Menaa C; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA., Zhang Y; Department of Pathology, Kaiser Permanente Medical Center Vallejo and Vacaville, Vallejo, CA, USA., Zhang L; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.; Center for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China., Jing D; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.; Center for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China., Azghadi S; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA., Zhou W; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.; Center for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China., Liu L; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA., Jiang N; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA., Li T; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA., Gao T; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA., Sweeney C; Department of Biochemistry and Molecular Medicine, University of California Davis, Sacramento, CA, USA.; NCI-Designated Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA., Shen R; Department of Pathology, Ohio State University, Columbus, OH, USA., Lin TY; Department of Biochemistry and Molecular Medicine, University of California Davis, Sacramento, CA, USA., Pan CX; NCI-Designated Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA.; Department of Internal Medicine, University of California Davis, Sacramento, CA, USA., Ozpiskin OM; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA., Woloschak G; Department of Radiation Oncology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA., Grdina DJ; Department of Radiation and Cellular Oncology and the Ludwig Center for Metastasis Research, The University of Chicago, Chicago, IL, USA., Vaughan AT; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.; NCI-Designated Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA., Wang JM; Chemoattractant Receptor and Signal Section, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA., Xia S; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA., Monjazeb AM; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.; NCI-Designated Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA., Murphy WJ; NCI-Designated Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA.; Department of Dermatology, University of California Davis, Sacramento, CA, USA., Sun LQ; Center for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China., Chen HW; Department of Biochemistry and Molecular Medicine, University of California Davis, Sacramento, CA, USA.; NCI-Designated Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA., Lam KS; Department of Biochemistry and Molecular Medicine, University of California Davis, Sacramento, CA, USA.; NCI-Designated Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA., Weichselbaum RR; Department of Radiation and Cellular Oncology and the Ludwig Center for Metastasis Research, The University of Chicago, Chicago, IL, USA., Li JJ; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA. jijli@ucdavis.edu.; NCI-Designated Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA. jijli@ucdavis.edu.

Publikováno v: Nature communications [Nat Commun] 2020 Sep 14; Vol. 11 (1), pp. 4591. Date of Electronic Publication: 2020 Sep 14.

A competing risks machine learning study of neutron dose, fractionation, age, and sex effects on mortality in 21,000 mice.

Autor: Wang, Eric¹ (AUTHOR) ew2717@cumc.columbia.edu, Shuryak, Igor¹ (AUTHOR), Brenner, David J.¹ (AUTHOR)

Publikováno v: Scientific Reports. 8/2/2024, Vol. 14 Issue 1, p1-13. 13p.

TP53 Mutational Status and ROS Effect the Expression of the Survivin-Associated Radio-Adaptive Response.

Autor: Murley JS; Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, Illinois 60637., Miller RC; Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, Illinois 60637., Weichselbaum RR; Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, Illinois 60637., Grdina DJ; Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, Illinois 60637.

Publikováno v: Radiation research [Radiat Res] 2017 Nov; Vol. 188 (5), pp. 579-590. Date of Electronic Publication: 2017 Aug 16.

Andrographis paniculata Diterpenoids Protect against Radiation-Induced Transformation in BALB/3T3 Cells.

Autor: Nantajit D; a   Department of Radiation Oncology, Chulabhorn Hospital, Bangkok, Thailand.; b   Research and International Relations Division, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand., Jetawattana S; c   Academic Service Unit, Thailand Institute of Nuclear Technology (Public Organization), Nakhon Nayok, Thailand., Suriyo T; d   Laboratory of Pharmacology, Chulabhorn Research Institute, Bangkok, Thailand., Grdina DJ; e   Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, Illinois., Satayavivad J; d   Laboratory of Pharmacology, Chulabhorn Research Institute, Bangkok, Thailand.; f   Chulabhorn Graduate Institute, Chulabhorn Royal Academy of Science.; g   Center of Excellence on Environmental Health and Toxicology, Office of Higher Education Commission, Ministry of Education, Bangkok, Thailand.

Publikováno v: Radiation research [Radiat Res] 2017 Jul; Vol. 188 (1), pp. 66-74. Date of Electronic Publication: 2017 May 11.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.